简介
Ming-Lung Yu graduated from the College of Medicine, Kaohsiung Medical University in 1989. He completed his clinical training in the Department of Internal Medicine and Hepatology at the Kaohsiung Medical University Hospital in 1994. Since then, he has focused his research on viral hepatitis and liver disease, both of which are prevalent in Taiwan. After completing his PhD at Kaohsiung Medical University,
Dr. Yu joined the faculty of the Department of Internal Medicine at this same institution as an Assistant Professor in 2000. He became Associate Professor in 2003, Professor of medicine in 2006 and was promoted to Chair Professor in 2020. A board-certified internist and gastroenterologist, he is recognized as a Clinical Principal Investigator (CPI) by the Academy of Pharmaceutical Physicians and Investigators.
In addition to his extensive teaching experience gained at the University Hospital, His research interests in the epidemiology and natural history of viral hepatitis have led him to publish more than 500 scientific original and review articles, including those on the molecular biology, viral kinetics, hepatocarcinogenesis and the optimization of antiviral treatment.
Prof. Yu holds various editorial roles, including the Distinguished Reviewer of JAMA Internal Medicine, the Consulting Editor of Clinical and Molecular Hepatology, the Academic Editor of PLoS ONE, the Associate Editor of the World Journal of Gastroenterology and a member of the editorial board of Hepatology, Kaohsiung Journal of Medical Science, and the Journal of Infectious Diseases. He was a Visiting Professor at the Liver Center, Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
He has served as the Senior Vice President at KMU, Superintendent at Kaohsiung Municipal Ta-Tung Hospital and the Vice President at Kaohsiung Medical University Hospital, both in Taiwan. Taken collectively, based on his achievements and contribution to HCV research, he is invited as a critical member of APASL and TASL HCV guidelines, policy-makers, and consulting experts on the Prevention of HBV, HCV of Health Promotion Administration, Ministry of Health and Welfare in Taiwan.
Ming-Lung Yu is now the President of Kaohsiung Medical University and a chair professor at the College of Medicine. He is also an adjunct chair professor at National Sun Yat-sen University (NSYSU). He was the dean of the College of Medicine, Center of Excellence for Metabolic Associated Fatty Liver Diseases and Senior Vice President of NSYSU from 2022 to 2024.
